PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
73.60
ESG score 1.1-1.2x SAVA's 63.11. Guy Spier would verify if superior ESG practices translate to better stakeholder relationships.
62.46
Similar environmental score to SAVA's 63.13. Bruce Berkowitz would investigate if industry environmental norms adequately address climate transition risks.
87.07
Social score exceeding 1.2x SAVA's 61.04. Mohnish Pabrai would examine if this social advantage creates sustainable talent and customer acquisition advantages.
71.26
Governance score 1.1-1.2x SAVA's 65.15. Guy Spier would verify if superior governance translates to better capital allocation and strategic execution.